These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Research on the inhibitors of fibrinolysis: the methods of measuring antistreptokinase, antiplasmin and antitrypsin]. GIACOMAZZI G Haematol Lat; 1961; 4():255-71. PubMed ID: 13898268 [No Abstract] [Full Text] [Related]
3. [Quantitative determination of antistreptokinase]. BERTOYE A; DETOLLE P Ann Inst Pasteur (Paris); 1952 Aug; 83(2):248-53. PubMed ID: 12986372 [No Abstract] [Full Text] [Related]
4. [Method of evaluation of antistreptokinase level of blood]. BERTOYE A; CARRAZ M; DETOLLE P C R Seances Soc Biol Fil; 1952 Sep; 146(17-18):1322-3. PubMed ID: 13020152 [No Abstract] [Full Text] [Related]
5. [Comparative study of antistreptokinase levels in normal subjects and in various diseases]. BERTOYE A; CARRAZ M; DETOLLE P Lyon Med; 1952 Oct; 187(42):241-52. PubMed ID: 13024200 [No Abstract] [Full Text] [Related]
6. [Determination of antistreptokinase titer in scarlet fever]. HOFFMANN H Dtsch Med J; 1952 Jun; 3(11-12):255-6. PubMed ID: 12979957 [No Abstract] [Full Text] [Related]
7. [Antistreptokinase activity of the blood plasma in subjects treated with cortisone]. TACCHI A; CREMONCINI CM Reumatismo; 1953; 5(Suppl. 2):218. PubMed ID: 13100796 [No Abstract] [Full Text] [Related]
8. [Simultaneous determination of 3 streptococcal antibodies--antistreptokinase, bacterial antihyaluronidase and antistreptolyin-O--in the blood serum of patients with acquired heart lesions]. STEPANIAN EP; PRIVALENKO MN; PETROSIAN MV Khirurgiia (Mosk); 1962 Feb; 38():13-8. PubMed ID: 13916860 [No Abstract] [Full Text] [Related]
9. [Contribution to the study of congenital immunity: the antistreptokinase titer in the mother, the full-time newborn, the premature infant and the suckling]. LI MOLI S; PISCONTI G Clin Pediatr (Bologna); 1961 Nov; 43():825-38. PubMed ID: 14464988 [No Abstract] [Full Text] [Related]
10. [On fibrinolysin-streptokinase treatment of thrombophlebitis, thromboses and thrombolism. (Preliminary report)]. KNOTH W Z Haut Geschlechtskr; 1962 May; 32():305-10. PubMed ID: 14457328 [No Abstract] [Full Text] [Related]
12. Review of clinical experience with clotlysing agents. CLIFFTON EE Am J Cardiol; 1960 Aug; 6():476-86. PubMed ID: 13810704 [No Abstract] [Full Text] [Related]
13. The use of fibrinolytic agents in the treatment of arterial occlusion. CLIFFTON EE; CLARKE RL Am J Surg; 1962 Feb; 103():173-9. PubMed ID: 13879949 [No Abstract] [Full Text] [Related]
14. [On practical execution of fibrinolysis therapy with enzyme preparations]. DEUTSCH E; FISCHER M; STACHER A Folia Haematol (Frankf); 1961 Oct; 6():310-7. PubMed ID: 13885851 [No Abstract] [Full Text] [Related]
15. The combined use of fibrinolytic and anticoagulant agents. Laboratory and clinical considerations. MOSER KM; HAJJAR GC Am J Cardiol; 1960 Aug; 6():496-502. PubMed ID: 13773043 [No Abstract] [Full Text] [Related]
16. [Clinical importance of antistreptokinase and antihyaluronidase titer]. CHRIST P; HAUSS WH Z Rheumaforsch; 1952 Apr; 11(3/4):84-7. PubMed ID: 14951671 [No Abstract] [Full Text] [Related]
17. [Behavior of antistreptokinase in blood of scarlet fever patients]. SALASSA RM; ANGELA GC Minerva Med; 1951 Jul; 42(46-47):131-4. PubMed ID: 14863230 [No Abstract] [Full Text] [Related]
18. [Examinations with antistreptokinase, antihyaluronidase and antistreptolysin reaction]. CHRIST P Z Rheumaforsch; 1953 Jun; 12(5-6):141-56. PubMed ID: 13103574 [No Abstract] [Full Text] [Related]
19. [On the problem of the importancdof antistreptokinase in rheumatism]. MELAMED KhI; GABRILOVICH IM Zdravookhr Beloruss; 1962 Dec; 8():19-22. PubMed ID: 13934629 [No Abstract] [Full Text] [Related]